VYNE Therapeutics Ownership | Who Owns VYNE Therapeutics?

VYNE Therapeutics Ownership Summary

VYNE Therapeutics is owned by 8.00% institutional investors, 4.31% insiders, and 87.69% retail investors. Nantahala capital management is the largest institutional shareholder, holding 2.34% of VYNE shares. Kennedy Micro Cap Opportunities is the top mutual fund, with 2.96% of its assets in VYNE Therapeutics shares.

VYNE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	VYNE Therapeutics	8.00%	4.31%	87.69%
Sector	Healthcare Stocks	232.20%	10.74%	-142.94%
Industry	Biotech Stocks	382.11%	10.55%	-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Nantahala capital management	1.00M	2.34%	$580.10K
Baker bros. advisors lp	851.35K	1.99%	$285.20K
Acadian asset management	638.49K	1.49%	$370.00K
Acorn capital advisors	586.57K	1.37%	$199.43K
Shay capital	492.58K	1.15%	$165.01K
Vanguard group	314.55K	0.74%	$182.44K
Ikarian capital	290.00K	0.68%	$97.15K
Geode capital management	225.15K	0.53%	$130.61K
Two sigma investments, lp	220.79K	0.52%	$73.96K
Boothbay fund management	106.46K	0.25%	$35.66K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Acorn capital advisors	586.57K	0.10%	$199.43K
Nantahala capital management	1.00M	0.02%	$580.10K
Harvest investment services	51.33K	0.02%	$84.69K
Rangeley capital	50.00K	0.01%	$16.75K
Shay capital	492.58K	0.01%	$165.01K
Ikarian capital	290.00K	0.01%	$97.15K
Staley capital advisers	36.47K	0.01%	$122.18K
Fny investment advisers	25.00K	0.00%	$14.00K
Corsair capital management	50.00K	0.00%	$16.75K
Gsa capital partners llp	53.96K	0.00%	$31.00K

Top Buyers

Holder	Shares	% Assets	Change
Nantahala capital management	1.00M	0.02%	1.00M
Baker bros. advisors lp	851.35K	0.00%	851.35K
Shay capital	492.58K	0.01%	492.58K
Two sigma investments, lp	220.79K	0.00%	220.79K
Acadian asset management	638.49K	0.00%	192.08K

Top Sellers

Holder	Shares	% Assets	Change
Eventide asset management	-	-	-1.39M
Cormorant asset management, lp	-	-	-1.37M
Adage capital partners gp	-	-	-644.13K
Dafna capital management	-	-	-636.10K
Kennedy capital management	-	-	-570.74K

New Positions

Holder	Shares	% Assets	Change	Value
Nantahala capital management	1.00M	0.02%	1.00M	$580.10K
Baker bros. advisors lp	851.35K	0.00%	851.35K	$285.20K
Two sigma investments, lp	220.79K	0.00%	220.79K	$73.96K
Two sigma advisers, lp	56.60K	-	56.60K	$18.96K
Harvest investment services	51.33K	0.02%	51.33K	$84.69K

Sold Out

Holder	Change
Cornerstone planning group	-2.00
Ashton thomas private wealth	-19.00
Centerpoint advisors	-350.00
Cwm	-500.00
Renaissance	-10.54K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	19	-38.71%	3,417,865	-12.90%	7	9.49%	9	-40.00%	2	-50.00%
Sep 30, 2025	29	-29.27%	3,326,375	-51.06%	7	3.07%	15	-31.82%	2	-77.78%
Jun 30, 2025	44	15.79%	8,048,768	12.39%	18	6.70%	22	-	12	71.43%
Mar 31, 2025	38	8.57%	7,161,761	1.37%	16	6.10%	22	15.79%	7	16.67%
Dec 31, 2024	1	-	36,472	-	-	1168.22%	-	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Kennedy Micro Cap Opportunities	493.02K	2.96%	493.02K
Vanguard US Total Market Shares ETF	373.32K	2.45%	-
Vanguard Total Stock Mkt Idx Inv	365.33K	2.19%	-7.99K
AlphaCentric LifeSci Healthcare I	310.50K	2.11%	-134.50K
AlphaCentric Life Sciences & Hlthcare I	268.49K	1.82%	-42.02K
Alger LIfe Sciences Innovation Composite	388.07K	1.52%	388.07K
Pleiades Small Cap Equity A	149.44K	0.90%	149.44K
AZ Equity Biotechnology A-AZ EUR Acc	91.08K	0.55%	2.50K
Vanguard Institutional Extnd Mkt Idx Tr	177.47K	0.53%	47.38K
Fidelity Extended Market Index	162.31K	0.49%	90.47K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 15, 2025	LEPORE PATRICK G	-	Buy	$43.80K
Nov 15, 2023	LEPORE PATRICK G	-	Buy	$50.78K
Mar 20, 2023	LEPORE PATRICK G	-	Buy	$49.68K
Mar 20, 2023	Harsch Mutya	Chief Legal Officer and GC	Buy	$25.00K
Nov 30, 2021	LEPORE PATRICK G	-	Buy	$12.70K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	1	-
2024 Q4	-	-
2024 Q3	-	-

VYNE Ownership FAQ

Who Owns VYNE Therapeutics?

VYNE Therapeutics shareholders are primarily institutional investors at 8.00%, followed by 4.31% insiders and 87.69% retail investors. The average institutional ownership in VYNE Therapeutics's industry, Biotech Stocks , is 382.11%, which VYNE Therapeutics falls below.

Who owns the most shares of VYNE Therapeutics?

VYNE Therapeutics’s largest shareholders are Nantahala capital management (1M shares, 2.34%), Baker bros. advisors lp (851.35K shares, 1.99%), and Acadian asset management (638.49K shares, 1.49%). Together, they hold 5.82% of VYNE Therapeutics’s total shares outstanding.

Does Blackrock own VYNE Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VYNE Therapeutics.

Who is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested?

Acorn capital advisors is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 586.57K VYNE Therapeutics shares, valued at 199.43K$.

Who is the top mutual fund holder of VYNE Therapeutics shares?

Kennedy Micro Cap Opportunities is the top mutual fund holder of VYNE Therapeutics shares, with 2.96% of its total shares outstanding invested in 493.02K VYNE Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools